Delegations of Authority and Organization; Office of the Commissioner

The Food and Drug Administration (FDA) is amending the general redelegations of authority from the Commissioner of Food and Drugs (the Commissioner) to other officers of FDA. The amendment delegates to the Deputy Commissioner for Policy and the Associate Commissioner for Policy Coordination authority to certify that a proposed or final rule, if issued, will not have a significant economic impact on a substantial number of small entities. Furthermore, the Deputy Commissioner for Policy has redelegated the aformentioned authority to certain FDA officials authorized to issue Federal Register documents. These actions are necessary to ensure the accuracy of the regulations.